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Abstract 
Depression is a common disorder that impacts one’s quality of life.  It can cause significant 
medical, social, and financial complications to an individual and affect others close to the person 
suffering from it.  Depression is often underrecognized and underdiagnosed in the primary care 
setting, which can lead to inadequate treatment.  Depression screening has been proven to be 
effective in detecting symptoms during an office visit.  The purpose of this quality improvement 
project was to implement a Patient Health Questionnaire (PHQ-9) depression screening process 
in a rural primary care clinic.  Based on the total score of the PHQ-9 screening test or if question 
number 9 is one or greater, the Columbia-Suicide Severity Rating Scale (C-SSRS) questionnaire 
was administered by the provider to further assess suicidal risk.  The goal was for 100% 
administration of the PHQ-9 screening tool to all non-acute patient visits.  Biweekly PDSA 
reviews were conducted, to evaluate the clinic’s progress and modifications were incorporated as 
needed.  During the 13-week project period, 312 patients completed the PHQ-9 and 13 scored 
high enough to be considered mild depression, and no patients met screening criteria for the C-
SSRS questionnaire.  The goal of 100% administration of the PHQ-9 questionnaire was achieved 
during the last month’s implementation at week ten and week twelve.  The PHQ-9 screening tool 
is a cost-effective way to detect symptoms sooner and allow the provider to help reduce the 
patient’s functional impairments, reduce the risk of suicide, and increase the likelihood of 
adhering with medical treatment.   
Key words: Depression, Patient Health Questionnaire, PHQ-9 Depression Screening, 
Primary Care, and Implementing Depression Screening.  
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Chapter One:  Introduction 
 Depression is a severe disorder that inflicts significant medical, social, and financial 
burdens on patients.  Depression conditions, such as major depressive disorder, can lead to 
increased morbidity and, consequently, cause mortality (Smithson & Pignone, 2017).  Despite 
the availability of effective treatments, depression in the primary care setting is often 
underdiagnosed (Rhee, Capistrant, Schommer, Hadsall, & Uden,  2018).  Depression screening 
has been proven effective in detecting symptoms during an examination, thus allowing the 
provider to address the problem.  Chapter One will explain why depression screening is 
important, address barriers to screening, and introduce the proposed DNP project.  
Background Information 
 Mental health problems, especially depression, are prevalent worldwide. In the United 
States (US), depression affects an estimated 16.2 million adults (National Institutes of Health, 
2017).  Various agencies have recognized the burden of depression and have developed 
strategies for improvements.  The World Health Organization (2019) established its UN 
Sustainable Development Goals and urges countries to take action to promote good mental 
health and well-being.  Healthy People 2020 has a goal of improving mental health via 
prevention and providing adequate mental health services (Office of Disease Prevention and 
Health Promotion, [ODPHP], 2019). 
 In the United States, depression is among the most common psychiatric disorders leading 
to disability and premature mortality (Akincigil & Matthew, 2017; Meyers, Groh, & Binienda, 
2014).  Depression affects one’s motivation to participate in health-improving behaviors.  On the 
other hand, chronic disease can harm one's mental health and ability to seek and participate in 
treatment.   
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  In special populations, such as the elderly, depression can be more challenging to detect 
than the younger patient.  Depression can mimic physical ailments that are common in older 
patients, such as fatigue, insomnia, and weight loss (Smithson & Pignone, 2017).  Patients with 
comorbidities such as cancer, neurologic problems, and cardiovascular disease are at higher risk 
for depression (Smithson & Pigone, 2017).  Without adequate screening, detection, and treatment 
for depression, patients are at higher risk for self-harm.   
Sheehan, Dubke, and Corrigan (2017) reported that 1.3 million Americans attempt 
suicide each year.  Suicide is the 10th leading cause of death in the US, accounting for 
approximately 43,000 deaths in 2014 (Office of Disease Prevention and Health Promotion, 
[ODPHP], 2019) and is the second leading cause of death for ages 25-34 years (Shepard, 
Gurewich, Lwin, Reed, & Silverman, 2016).  Kim and Lee (2017) studied risk factors that 
increase the elderly’s suicidal thoughts and suicide attempts.  Their study found that negative 
perceptions of one’s health correlated with increased emotional instability and increased risk of a 
suicide attempt.  
Significance of Clinical Problem 
Epidemiology.  Depression is widespread through all demographics.  It is the most 
prevalent mental health disorder in the United States (Meyers et al., 2014).  The approximate 
lifetime prevalence of major depressive disorder in US adults is 20.6%, with a yearly prevalence 
of 10.4% (Hasin et al., 2018).  Depression occurs twice as often in women than in men, has a 
peak prevalence in the second or third decades of life, and then has a subsequent modest peak in 
the fifth and sixth decades (Malhi & Mann, 2018). 
Interpersonal impact.  Depression disorders can cause suffering, decreased quality of 
life, and impaired functioning in severe cases.  Meyers, Groh, and Binienda (2014) predicted 
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depression to be the leading cause of disability by 2030.  Depression can affect others close to 
the individual, including spouses, children, employees, and friends, both emotionally and 
financially.  
Depression: economic impact.  The economic impact of depression on society has an 
annual cost exceeding approximately $80 billion in the United States (Deneke, Schultz, & 
Fluent, 2015).  Chow, Doane, Sheehan, Alphs, and Le (2019) explains that about 45% of the 
total economic burden of depression is related to higher direct medical cost, such as primary care 
and emergency department visits, and hospitalizations.  It was estimated that for every dollar 
spent on direct cost, $6.60 was spent on “comorbidities, workplace cost, and suicide-related 
cost” (Chow, Doane, Sheehan, Alphs, & Le, 2019, p.1).   
The national cost of suicide attempts and suicides in the US is approximately $58.4 
billion (Shepard, Gurewich, Lwin, Reed, & Silverman, 2016).  The Suicide Prevention Resource 
Center (2020) reported the average cost of one suicide was approximately 1.3 million dollars, 
with more than 97% due to lost productivity.  Screening to detect depression, and prevent 
associated suicide, would result in a favorable cost-benefit investment for the US (Shepard et al., 
2016).   
 Depression and chronic disease.  Depression is strongly associated with chronic 
diseases such as cardiovascular and cerebrovascular disease, cancer, diabetes, and obesity 
(Meyers et al., 2014; Petrosyan et al., 2017).  Depression’s negative consequences increase 
mortality rates (Deneke et al., 2015).  Depressed patients are more likely to be nonadherent with 
medical treatment, have decreased self-care, increased impairment, and increased medical costs 
compared to the general population (Meyers et al., 2014).   
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Depression treatment.  In January 2016, the U.S. Preventative Services Task Force 
(USPSTF) recommended screening for depression in the general adult population with “adequate 
systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up” 
(Siu et al., 2016, p. 380).  Primary care is where most people seek healthcare, and where often, 
depression is managed (Petrosyan et al., 2017; Zivin & Katon, 2015).  The efficacy of depression 
screening increases with access to treatment and collaborative care (Narayana & Wong, 2015).  
Treatment with antidepressants or psychotherapy improves one's overall health and decreases the 
risk of self-harm (Olfson, Blanco, & Marcus, 2016).  Depression increases the risk of self-harm, 
and primary providers should be able to accurately screen for suicidal risk as well (Viguera et al., 
2015).  Akincigil and Matthews (2017) reported the percentage of people experiencing 
symptoms of depression in primary care settings to be up to 8%, and up to 45% of people who 
died by suicide visited a primary care provider within one month before the suicide.    
Depression screening.  Screening for depression is an essential step in diagnosing and 
managing this disorder.  There are multiple mental health screening tools available for use in the 
outpatient setting.  These tools include two forms of the Patient Health Questionnaire (PHQ-2 
and PHQ-9), the Geriatric Depression Scale, the Edinburg Postnatal Depression Scale for 
postpartum women, and the Columbia-Suicide Severity Rating Scale (C-SSRS).  The optimal 
time to screen for depression is not well established in the literature.  Narayana and Wong (2015) 
explained that screening would be most beneficial at an early stage or treatable stage of the 
depression.  Therefore, a practical approach, in a primary care practice, would be to screen all 
adults at their regular wellness visit (Savoy & O’Gurek, 2016).   
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Question Guiding Inquiry (PICO) 
 The proposed project site, a primary care clinic in rural North Carolina, currently does 
not screen patients for depression.  The clinic is interested in implementing a depression 
screening process to improve overall well-being for their patient population. 
 Population.  A primary care provider, certified medical assistant, and a secretary will be 
responsible for screening patients for depression.  The clinic has approximately 2,000 active 
patients.  The clinic’s population consists of adults ages 18 years and older, living in the 
surrounding area.  Approximately 75% of their clients are Medicare recipients. Other clients 
include disabled, Medicaid, private insurance, or self-pay individuals. 
Intervention.  Before implementation, the staff will be educated on the purpose and 
procedures for administering the PHQ-9 and C-SSRS screening tools.  The secretary will 
administer the depression screening tool when he/she prepares the patient for a non-acute 
appointment.  The certified medical assistant will collect the PHQ-9 screening tool during her 
patient check-in process and enter the score into the electronic medical record.  The provider will 
review the screening and calculate the final score.  If the total score of the PHQ-9 is 14 or greater 
or if item 9 number is one or greater, the provider will administer the C-SSRS questionnaire.  
During the patient assessment, the provider will discuss the screening results and determine, if 
indicated, an appropriate treatment plan.  The provider can then determine resources that will be 
beneficial to the patient at the time of diagnosis.  The secretary will ensure the screening is coded 
correctly to receive reimbursement from governmental or insurance agencies. 
Comparison.  The clinic site does not currently use any tool for depression screening.  
The goal of the project will be to implement screening with 100% of the clinic’s established 
patients at non-episodic appointments.   
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Outcome(s).  Evidence-based screening of patients will take place during a 13-week 
period.  Based on the score of the PHQ-9 and C-SSRS screening, interventions will be 
implemented for patients exhibiting evidence of depression.  The anticipated long-term outcome 
is to increase early identification of depression in the clinic’s established patient population, 
along with successful treatment interventions for patients experiencing depression. 
Summary 
 Depression has a significant negative impact on affected individuals. It is a debilitating 
disease that may lead to a financial burden.  The World Health Organization and the U.S. 
Preventative Services Task Force set goals to improve the quality of care for people with 
depression.  Primary care is a direct avenue for achieving these goals.  An essential first step is 
becoming better at detecting depression, then managing the treatment plan.  The purpose of this 
project is to implement a depression screening process on an initial or annual physical exam for 
all patients age 18 years and older.  The goal is to transition the depression screening into the 
clinic to become standardized care. 
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Chapter Two:  Overview of the Literature 
 The goal of this project is to implement an evidence-based depression screening tool for 
recognizing depression in the primary care setting.  A review of the literature supports the 
importance of depression screening and the impact it can have on a patient’s plan of care and 
overall well-being.  This chapter will highlight the methods, findings, and conclusions of the 
literature review. 
Literature Appraisal Methodology 
 Sampling strategies.  A literature review performed in PubMed resulted in 413,250 
articles related to “depression.”  When MESH terms were narrowed to “major depressive 
disorder” and “patient health questionnaire,” a total of 131,977 articles emerged.  Further 
narrowing of criteria specific to primary care setting, within five years of publication, and adults 
19 years + in age, decreased the number of articles significantly to 2,055.  Another search term 
of “PHQ-9 depression screening” was added to the last MESH and produced 35 peer-reviewed 
articles published within the past five years.   
Another search was performed via the One-Search database.  The initial keywords used 
were "adults and older adults with depression," which yielded 854,328 results.  Advanced search 
with peer-reviewed, last five years, and English language criteria decreased the results to 
123,504.  Additional keywords of "depression screening" and "implementing depression 
screening" decreased the results further to 4,262.  Adding advanced search terms “process 
measures,” “depression screening instruments,” “PHQ-9,” “primary care,” and “improvement in 
depression screening” resulted in 83 articles.  After combining the two searches, removing 
duplicate articles, and reviewing abstracts of potentially eligible articles, 32 articles were 
identified for the literature review (Appendix A). 
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Evaluation criteria.  Inclusion and exclusion criteria were employed for the review 
process on screening for depression.  Articles selected were based in primary care settings in 
both rural and urban areas, adult population, and evidence surrounding best practices and 
guidelines for depression screening.  The level of evidence from articles reviewed ranged from 
Level I to Level VII (Appendix B). 
Articles excluded in the review were studies done in other countries or tertiary care 
settings. Exclusion criteria eliminated populations related to pregnant women, adolescents, and 
children.  Other articles excluded were comprised of research focused solely on treatment 
modalities rather than screening.   
Literature Review Findings 
 Depression is prevalent in both genders, all ages, races, and is among the leading causes 
of disability in people 15 years and older (Agency for Healthcare Research and Quality [AHRQ], 
2019).  The World Health Organization reported depression to be the leading cause of disability 
among women, causing a loss of billions of dollars in productivity and annual medical care costs 
in the US (AHRQ, 2019).  Zivin and Katon (2015) state that depression is a predominant mental 
condition in primary care clients, especially ones with chronic medical conditions.  Depression is 
common in older adults as well, with approximately 10-15% of geriatric patients having a 
depressive disorder (Samuels et al., 2015).   
Despite effective treatments being available, depression is significantly under-diagnosed 
(Jiao, Rosen, Bellanger, Belkin, & Muennig, 2017; Pfoh, Mojtabai, Bailey, Weiner, & Dy, 
2015).  Improving the screening of depression could decrease the burden of the disorder by 
providing adequate treatment (Jiao et al., 2017).  Three common trends supported by the 
Depression Screening 18 
literature review are that depression screening is underutilized, the PHQ-9 screening tool is 
effective, and screening is useful only if treatment is readily available to the patient.  
 Depression screening.  The first recurrent finding in the literature review is screening for 
depression in primary care settings is low.  A small percentage of patients with depression are 
treated in the primary care setting (Kearney, Wray, Dollar, & King, 2015; Olfson et al., 2016; 
Petrosyan et al., 2017).  Pfoh, Mojtabai, Bailey, Weiner, and Dy (2015) performed a cross-
sectional study to evaluate depression screening compliance with Medicare beneficiaries aged 65 
years and older and discovered screening to be minimal.  In the study, Medicare or low-income 
patients had the smallest percentages for depression screening in the primary care setting (Pfoh et 
al., 2015).   
 Routine primary care screening is an integral part of improving diagnosis rates and 
reducing the overall burden of depression (Jiao et al., 2017; Narayana & Wong, 2015).  The 
USPSTF guidelines were established when agencies targeting the mental health needs of the 
American population found that screening improves the accuracy of identifying depression in 
primary care settings (Siu et al., 2016).  Rhee et al. (2018) point out that the function of the 
screening tool is to alert the primary care provider of the possible presence of depression.  Thus, 
should the PHQ-9 screening tool alert the possibility of suicidal thoughts, it is of utmost 
importance for the provider to screen for this as well.  As many as 45% of suicide victims saw a 
physician within a month preceding their death (Viguera et al., 2015).  Screening for both 
depression and, if needed, suicide risk will enhance approaches to evaluate the condition and 
improve patient safety (Viguera et al., 2015). 
 Screening tools.  The second recurrent finding in the literature review is that there are 
many depression screening tools available.  The most commonly used is the PHQ-9 because it 
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has been proven to be high in sensitivity and specificity and cost-effective (Jiao et al., 2017; 
Mitchell et al., 2016).  Jiao et al. (2017) studied the cost-effectiveness of the PHQ-2 and PHQ-9  
tools in New York City.  In the study, the authors found that using the PHQ2/9 screening with 
collaborative care was significantly less expensive than most clinical preventative interventions, 
such as HIV lab tests to screen for high-risk patients.  Beard, Hsu, Rifkin, Busch, and 
Björgvinsson (2016) utilized the PHQ-9 in a large sample of patients, and the tool was found to 
correlate well with other established tools and considered the PHQ-9 to be a valid screening tool. 
The PHQ-9 is the most commonly used screening tool in primary care settings (Mitchell, 
Yadegarfar, Gill, & Stubbs, 2016) (Appendix C).  The authors performed a meta-analysis to 
determine the validity of the PHQ-9 tool.  Overall, their results, along with other meta-analyses, 
confirmed high sensitivity and specificity for the PHQ-9 screening tool (Mitchell et al., 2016; 
Narayana & Wong, 2015).  The PHQ-9 is a self-assessed questionnaire tool that screens for and 
measures depression severity (Barnacle, Strand, Werremeyer, Maack, & Petry, 2016).  This 
reliable screening tool is popular due to its ease of patient completion, ease of provider 
interpretation, and free availability to providers.  The PHQ-9 has been used across different 
medical populations, in multiple countries, and is available in various languages (Beard, Hsu, 
Rifkin, Busch, & Björgvinsson, 2016).  Item 9 of the PHQ questionnaire assesses the presence of 
recent thoughts of death and self-harm. 
The C-SSRS is a screening tool designed to assess suicidal ideation (Appendix D).  This 
tool is also a quick questionnaire, evidence-supported, appropriate for all ages, and is available to 
the provider free of charge (The Columbia Lighthouse Project, 2016).  It measures whether 
potential suicide risk is present and has separate assessments for suicidal thoughts and behaviors.  
A limitation with this tool is associated with differences in the consistency in ratings by 
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providers.  Nonetheless, the Food and Drug Administration has recommended this tool to be 
used in suicidal risk clinical trials (Viguera et al., 2015).  The Columbia Lighthouse Project 
(2016) endorses the C-SSRS as a validated tool for the primary care setting after the PHQ-9 has 
warranted further assessment. 
Viguera et al. (2015) performed a retrospective analysis of PHQ-9 and C-SSRS data over 
four months and found both the screening tools identified suicidal risk with high sensitivity.  
However, when compared to clinical assessments, the researchers found the specificity of the C-
SSRS to be higher than item 9 of the PHQ-9.  The researchers recommend using a more efficient 
2-step process when screening for suicide risk.  They suggest administering the C-SSRS only if 
item 9 on the PHQ-9 is one or greater, or if the provider’s assessment warrants a suicidal risk 
potential.  This 2-step approach will decrease the false-positives of suicide risk and decrease the 
service demands for follow-up (Viguera et al., 2015).  
 Resource availability.  A third recurrent finding in the literature review is that screening 
is useful only if there are resources readily available for the patient with a depression screening 
positive for symptoms (Deneke et al., 2015; Jiao et al., 2017; Viguera et al., 2015; Zivin & 
Katon, 2015).  Resources that can be utilized, if available, to treat patients with depression 
include pharmacological and nonpharmacological interventions via collaborative care.  
Collaborative care, defined by Deneke et al. (2015), is having systems in place to facilitate 
patient support and treatment.  For example, support staff to help with patient education, 
adjusting treatment plans, follow-up conversations, serving as a link between the primary care 
setting and the mental health setting as needed.  Collaborative care is cost-effective for long-term 
care of depression (Deneke et al., 2015). 
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             Provider training.  Providers are the gateway to improving the detection and diagnosis 
of depression in the primary care setting.  Sikorski, Luppa, Konig, Bussche, and Riedel-Heller 
(2012) performed a systematic literature review of studies providing training to providers in 
sustaining an implemented generalized intervention.  In their research, only providing education 
to the provider found no change in symptoms or improvement in treatment.  By introducing 
additional guidelines, such as an algorithm, and more complex interventions, such as 
collaborative care, showed a significant change in the health outcomes of patients.  The 
researchers concluded that providing guideline implementation with provider training enhances 
care for depression in the primary care setting.  At the target site, the provider will be educated 
on the PHQ-9 diagnostic algorithm, which will notify the provider of the severity of the 
depression and proposed treatment actions (Pfizer, Inc., 2017). 
Limitations of the Literature Review Process 
 Some limitations emerged during the literature review process.  Most of the research was 
conducted in fields other than nursing.  There is minimal research on the optimal timing of 
performing the depression screening.  The effect of depression-imposed cost on an individual 
was rarely addressed.  Finally, research on depression screening for older adults is not prevalent.   
Discussion 
 Conclusion of finding.  The current literature identifies depression as a significant public 
health problem.  It causes suffering, decreased quality of life, disability, financial burdens, and 
may lead to more serious ramifications, such as self-harm (Akincigil & Matthew, 2017; Deneke 
et al., 2015; Meyers et al., 2014).  Depression impacts others close to the affected person and can 
increase public economic burdens (Jiao et al., 2017).  Though it is a prevalent mental disorder in 
the US, it is often under-detected and undertreated in primary care. (Kearnery et al., 2015).   
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Depression screening in primary care settings can increase the detection of depression in 
the general population.  Agencies such as the World Health Organization, Healthy People 2020, 
and the U.S. Preventative Services Task Force have recognized the need to improve mental 
health and recommend improving depression screening rates.  All patients in the primary care 
setting should be screened at least annually and, for patients identified with depression, during 
follow-up appointments to assess treatment progress (Akincigil & Matthew, 2017; Meyers et al., 
2014).  
Literature supports that implementing and sustaining a depression screening process is 
vital to improve the care of depressed patients (Smithson & Pignone, 2017).  When screening 
tools are used with resources for the management of the illness, patient outcomes improve 
significantly (Smithson & Pignone, 2017).  Collaborative care has been shown to enhance the 
patient’s overall well-being (Jiao et al., 2017; Kwan, Chadha, Hamer, Spagnolo, & Kee, 2017; 
Zivin & Katon, 2015).  Implementing PHQ-9 depression screening at the project site will be vital 
to improving the detection, diagnosis, and treatment of depression in the clinic's population.    
Educating and training providers to implement a specific tool is crucial to implementing 
the screening process (Sikorski et al., 2012).  Providing a guideline to adhere to may provide 
enhanced sustainability for depression screening at the project site.  
 Advantages and disadvantages of findings.  There are advantages to implementing 
depression screening in identifying patients with depression symptoms that may otherwise go 
undetected.  Screening will improve the rates of depression diagnosis and may eventually reduce 
the burden of depression on an individual (Meyers et al., 2014).  The PHQ-9 has been proven to 
be a reliable, validated tool in screening for depression.  The PHQ-9 and C-SSRS screening tools 
are valuable for the provider to be able to evaluate the mental state of his/her patient.  The 
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identification of depression allows the patient to receive the advantages of treatment for the 
depression. 
  A disadvantage of implementing the PHQ-9 screening tool is that the patients will be 
self-reporting the results before seeing the provider.  Based on the score, the provider will initiate 
a discussion during the patient exam.  Doing so may increase the chance of under-diagnosis or 
misdiagnosis, which may lead to inappropriate pharmacological and psychiatric services (Rhee et 
al., 2018).  
Other disadvantages may be secondary consequences for staff or patients.  An increase in 
workload for the staff members of the clinic and increased provider-patient examinations may be 
viewed negatively by staff.  Another possibility is that patients may be sensitive to the stigma 
related to depression and thus not want to participate in screening or answer the questionnaire 
honestly (Rhee et al., 2018). 
          Utilization of findings in the practice change.  Early identification of patients with 
depression via PHQ-9 screening and C-SSRS in a rural primary care clinic can influence the 
patient population’s overall well-being.  Staff will be educated on the importance of depression 
screening, how to administer the PHQ-9, calculate the PHQ-9 score, and when to administer the 
C-SSRS.  The provider will be educated on the diagnostic algorithm for the PHQ-9 (Pfizer, Inc., 
2017).  All patients, age 18 and higher, will be screened at annual non-acute scheduled exams.  
Providers will need to plan for extra exam time allotted for depression screening and treatment 
counseling.  If the PHQ-9 score is 14 or higher or item number 9 score is one or greater, the C-
SSRS will be administered.  Ongoing follow-up will be utilized to monitor the patient’s progress.  
PHQ-9 screening will be administered again on a patient at a follow-up exam to measure 
Depression Screening 24 
outcome improvement.  Implementing this stepwise care approach is critical to a successful 
integration process (Kearney et al., 2015). 
Summary 
 The Healthy People 2020 objectives for mental health and mental health disorders are to 
reduce the percentage of adults aged 18 and older, with depression, increase the proportion of 
adults that receive treatment, and increase depression screening in primary care settings.  
Identifying depression with valid screening tools will allow for patients to have access to 
treatment, assess the quality of treatment, and increase their quality of life.  Implementing the 
PHQ-9 depression screening will allow the clinic to help achieve the goals set by the Office of 
Disease Prevention and Health Promotion.  
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Chapter Three:  Theory and Concept Model for Evidence-based Practice 
 The goal of this project is to design and implement a protocol for depression screening in 
a primary care clinic.  The key concepts embedded throughout the project are depression, 
standard screening, primary care, and the desired project outcomes.  The design of the project is 
guided by two frameworks:  Lewin's Change Theory and the Plan-Do-Study-Act Cycle.  Chapter 
three will define and discuss these four concepts and the two frameworks. 
Concept Analysis  
 Depression.  Depression can range from a mood occasionally experienced by an 
individual to a medically diagnosed, persistent condition.  Any person can experience symptoms 
of depression, such as generalized discontent, loss of interest, or sadness resulting in a depressed 
mood.  Having a depressed mood from time to time is ordinary and unremarkable.  When the 
symptoms are persistent, generally lasting greater than two weeks, they are indicative of a 
disorder (Malhi & Mann, 2018).  The onset of depression is typically gradual, and its course 
throughout one's life varies in an episodic series of ups and downs.  Best described by Malhi and 
Mann (2018), depression is a lifelong cycle of feel-well periods interrupted by recurrent 
depressive episodes. 
 A medical diagnosis of depression is based on the number of symptoms that indicate a 
dysfunction or impairment that lasts longer than two weeks at a time (Malhi & Mann, 2018).  
Some symptoms are highly correlated with medical depression, such as an inability to experience 
pleasure from a previously enjoyable activity, feelings of worthlessness and guilt, fatigue, and 
suicidal ideation, plan or attempt.  The Diagnostic and Statistical Manual of Mental Disorders 
(DSM)-5 states major depression is indicated by the exhibition of at least five of their identified 
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symptoms nearly every day during the same 2-week time frame (Malhi & Mann, 2018).  A high 
number of severe symptoms increases the risk of functional impairment (Malhi & Mann, 2018). 
 Standardized screening.  Detecting depression can be difficult because of its many 
different forms of manifestation.  As providers increase their awareness and diagnosis of 
depression, their ability to implement plans will also increase (Malhi & Mann, 2018).  Utilizing a 
standard screening tool can assist a care provider in distinguishing both the existence and 
severity of symptoms.  The PHQ-9 is a popular tool in the primary care setting and can guide 
clinicians in the detection and severity of the depression. 
 The PHQ-9 consists of a nine-item, self-administered questionnaire that includes four 
possible responses for each item.  According to Pfizer, Inc. (2017) PHQ Instruction manual, to 
calculate the scores, patient responses of  “not at all,” “several days,” “more than half the days,” 
and “nearly every day,” are assigned scores of 0, 1, 2, 3 respectively.  The PHQ-9 total score can 
range from 0 to 27, with benchmark scores of 5, 10, 15, and 20 representing severity cut-points 
for mild, moderate, moderately severe, and severe depression, respectively.   
The instruction manual provides additional clinical considerations that may affect the 
provider’s diagnosis and management of depression.  Providers must assess the whole situation 
during the examination and use clinical judgment rather than relying solely on the PHQ-9 score 
(Malhi & Mann, 2018).  For example, the manual suggests considering if current symptoms are 
triggered by stressors, how long symptoms have been present, has treatment already been 
provided, and is there any patient history or family history of similar conditions.  
The manual further defines an algorithm for proposed treatment plans based on the 
severity of the total PHQ-9 score.  A score 0 to 4 indicates none to minimal depression severity 
and requires no treatment actions.  Mild depression, score 5 to 9, suggest watchful waiting and 
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repeat PHQ-9 at the next follow-up visit.  A score of 10 to 14 is categorized as moderate 
depression and counseling, follow-up, and pharmacotherapy should be considered.  Moderately 
severe has a score of 15 to 19, and active treatment is advised with pharmacotherapy and 
psychotherapy.  A score of 20 to 27 is considered severe depression, and immediate 
pharmacotherapy is suggested.  If the provider perceives severe impairment, he/she should 
quickly facilitate a referral to a mental health specialist and collaborative management.   
The C-SSRS is a screening tool that assesses a person’s suicide risk, suicide ideation, 
suicidal planning in progress, and any attempt toward self-harm.  If a patient’s response is a one 
or greater on item number 9 on the PHQ-9 tool, or the total score is 14 or greater, the C-SSRS 
should be given to assess suicide risk. 
Primary care.  Primary care is provided in an outpatient healthcare facility that offers 
internal medicine care for clients.  Primary care includes health promotion, disease prevention, 
diagnosis and treatment of acute/chronic illnesses, patient education, and health maintenance 
(American Academy of Family Physicians, 2019). 
   Project Outcome.  The outcome of the project is an implementation of depression 
screening at a primary care site.  Weekly reviews will be conducted to evaluate the process 
toward improvement and modifications in the implementation plan will occur as the project 
unfolds.  The outcome is to have 100% of non-acute patients screened for depression.  
Theoretical Framework 
 Naming the theory.  Changing people's behavior is difficult and sustaining the change 
over time can be a challenge.  The extent to which staff and patients at the target site implement 
new screening procedures and embrace associated change will depend on the ability of the 
project implementation process to alter the environment and culture in which the individual 
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function.  Anticipating the difficulty of change and understanding the change process, in general, 
will help guide planning for the successful implementation of depression screening.  
 Utilizing Kurt Lewin’s Change Theory as a basis for designing the DNP project will help 
guide the implementation of the screening process.  Lewin’s theory has set standards for many 
organizational change management programs (Butts & Rich, 2017).  Lewin was a behavioral 
scientist who developed his model for change in the 1940s and is still in use today (Butts & Rich, 
2017).  His model for changing human behavior utilizes a three-step process of change known as 
unfreeze-change-refreeze. 
 Lewin described change as a driving force within an organization that is opposed by 
participants toward the change (Butts & Rich, 2017).  It was essential to understand the process 
of change in order to get people's support during each stage of change.  The change model can 
best be described by using the analogy of changing the shape of ice from a cube to a cone 
(MindTools, 2019).  Wanting to change the shape of the ice from a cube to a cone, one would 
need to unfreeze the ice cube converting it to water, thus eliminating the previous shape while 
preserving the original elements.  Then one freezes the water into a new shape, utilizing the 
original elements but altering the shape. (Figure 1) 
 
Figure 1.  Lewin’s Change Management Model (MindTools, 2019) 
 Applying this model to changing an organization's practice, the first stage of the model is 
to "unfreeze" the original piece.  Unfreezing includes preparing the organization to accept that 
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the change is needed.  It will be important to have a powerful message to explain, in advance, 
why the change is necessary (MindTools, 2019).  The second stage of applying the model is 
“change,” or reshaping the original elements from the old shape to the new shape.  Change is 
when people will begin to accept the absence of the original state of being and start participating 
in re-assembling the existing elements into a new form and support the new intervention.  The 
last stage is “refreeze,” or the solidification of the new shape of elements, or the 
institutionalization of change.  To bring closure to this stage, people must have internalized the 
transition and made the new way of things part of their culture.  When this state is solidified, 
participants will feel comfortable with the new ways of working, and the change will become 
sustainable in practice (MindTools, 2019). 
Application to practice change.  Lewin’s Change Theory has been utilized to format the 
DNP project and to guide the transition from a state of no depression screening to incorporating a 
screening process.  When the topic of depression was discussed initially with staff, it was 
discovered that no screening was provided.  The first step was to identify a project champion, 
who is also the clinic’s physician, and to receive site approval for planning and to implement a 
standardized depression screening process (thawing the cube).  The remainder of the clinic staff, 
the certified medical assistant and secretary, were then engaged in the initial introduction and 
explanation of the use of a depression screening tool (working with the existing elements to 
create a new shape).  This was the beginning of establishing the need and shaping changes the 
DNP project would bring to clinic operations.  The next reshaping step will include staff 
education on the PHQ-9 and C-SSRS screening tools and the provider education on the PHQ-9 
treatment algorithm.  Administering the tools, evaluating the process based on the results, and 
formulating a treatment plan for identified patients will be the next steps in the change process 
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(refreezing the water).  The project goal will be accomplished when the staff incorporates the 
screening tools into everyday workflow. 
EBP Change Theory  
Naming the change model.  Lewin’s Change Theory provided a context in which to 
shape the DNP project.  The Plan-Do-Study-Act (PDSA) change model will help guide clinical 
decision-making during the implementation of the project's intervention.  The PDSA model aids 
in evaluating and making mid-course adjustments based on a small test of change.  This model 
allows one to test a concept, evaluate the change, improve it, and then test again.  Coury et al. 
(2017) acknowledged that the PDSA model is often used in the health care setting to improve the 
quality of patient care. 
The Institute of Healthcare Improvement (2019) recommends using the PDSA for a 
quick, small test of change.  Keeping the test on a small scale will allow the evaluator to adjust 
the process throughout the test.  Calderwood, Mahoney, and Jacobson (2015) used the PDSA 
model to  improve bowel preparation for colonoscopy procedures.  The researchers performed 
several rapid PDSA cycles over one year.  They found a progressive improvement in percentages 
of bowel preparation after adjusting PDSA cycles throughout the year. 
The PDSA cycle can be illustrated as a circle comprised of four quadrants. (Figure 2) 
Each quadrant represents a step in the cycle, beginning with the upper right quadrant and 
progressing in a clockwise direction.  The “plan” quadrant involves determining and defining the 
change that will take place in the practice setting.  Benchmark data from other sources will 
facilitate setting outcome goals and comparing the project’s performance against goals. It is best 
if the method of measuring outcomes and determining the degree of change is objective and easy 
to evaluate (Morelli, 2016).  The change implementation process needs to be outlined, 
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responsibilities delegated appropriately, and one person in charge of overseeing the process 
(Morelli, 2016).  The “do” quadrant involves implementing the intervention plan.  Collecting 
data will be part of this step as well.  The “study” quadrant involves determining the degree to 
which the intervention was successful by comparing performance data with predictions and 
target goals.  If desired results are not achieved, then adjustments are needed, and the “act” 
quadrants involve identifying needed adjustments and moving back to the "plan" quadrant to 
construct modifications that will facilitate improved movement toward desired outcomes.  The 
cycle is repeated until satisfactory outcomes are achieved. 
 
Figure 2.  Model of Improvement (Institute for Healthcare Improvement, 2019) 
Application to practice change.  Planning for the DNP project began with assessing the 
need for depression screening at the target site.  Discussion with the project champion and office 
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staff illuminated an absence of depression screening and a need to implement a screening tool.  
Educating staff on the incidence rates of depression and the negative consequences of untreated 
depression helped prepare and motivate them for future change.  The project goal is 100% 
administration of the screening tool for all non-acute patient visits.  Weekly data collection will 
occur over a 13-week implementation period.  A review of weekly data will determine if any 
adjustments are needed in the intervention to achieve a higher success rate.  If adjustments are 
indicated, necessary changes will be instituted with the continued weekly evaluation of the 
process. 
Summary  
 Theories and models emerging from research have historically been instrumental in the 
evolution of the nursing practice.  Research and its associated application to change in practice 
have provided a foundation for improving clinical practice and decision-making.  Adhering to a 
theoretical framework keeps the change initiative focused, and a change model keeps a change 
initiative organized.  Organizational and institutional change is difficult and can only be 
successful when skillfully planned with a keen focus on stakeholders’ buy-in and individuals 
whose behavior needs to change. 
 Lewin's Change Model is a simple and straightforward framework to manage change.  
Recognizing the three distinct stages of change, unfreeze-change-refreeze, will enhance change 
through communication and allow people to embrace the new ways of working.  To ensure the 
change is developed systematically, the PDSA method will help to improve the change process 
and will be essential to conclude the intervention's effectiveness. 
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Chapter Four:  Pre-implementation Plan 
This chapter will describe the purpose of this project, how it will be implemented, data 
collection tools that will be used, and how to evaluate if the process has made improvement.  The 
ethical aspects of project implementation and financial analysis in the feasibility of the project 
will be described.  
Project Purpose 
 The purpose of this project is to implement a depression screening process in a primary 
care practice.  The PHQ-9 depression screening tool was used for diagnosing, monitoring, and 
evaluating the severity of depression.  Additionally, the C-SSRS questionnaire will be given to 
assess suicide risk in patients who answer positively to item number nine on the PHQ-9, or if the 
total score is higher than 14.  The provider assessed the patient and determined the best treatment 
plan based on his/her assessment and findings. 
Project Management 
Organizational readiness for change.  The organization’s provider, who is also the 
owner, was approached regarding implementing a standardized process in depression screening 
when it was identified that screening was not currently being done.  The provider verbalized that 
there was a need present for the patient population and agreed to support the implementation of 
the project at the primary care site and serve as project champion.  The project leader discussed 
the implementation of a depression screening process with the certified medical assistant (CMA) 
and secretary.  All three participants were interested in learning about the PHQ-9 screening tool 
and receptive to participating in implementing a screening process.   
Interprofessional collaboration.  Initiating discussion of the screening tool process with 
all three participants helped to improve implementation coordination and communication.  The 
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secretary and CMA described a typical workday, and through discussion, a decision on when to 
administer the PHQ-9 screening tool was decided.  Obtaining the participants’ input and buy-in 
is vital for the implementation of the screening tools to be successful and sustainable. 
 As the patient approaches the front desk to check-in for his/her scheduled appointment, 
the secretary requested the patient to fill out the PHQ-9 screening tool while waiting to be seen.  
The secretary will verbally explain the purpose of the screening and steps on how to answer the 
questions.  Patients were assessed by the secretary on the need for a translated version of the 
questionnaire or if assistance was needed to complete the form. 
The certified medical assistant ensured the screening was fully completed and calculated 
the total score.  The CMA recorded the score in the patient’s electronic chart and informed the 
provider of the patient’s score.  The score will also be recorded on a data collection tool by the 
medical assistant for use in evaluating the project process toward improvement.  
The provider was responsible for interpreting the PHQ-9 scores and administering the C-
SSRS as needed.  The best plan of care was based on the screening score(s) and the provider’s 
assessment of the patient.  
Risk management assessment.  A SWOT analysis was used to identify the 
organization’s strengths and weaknesses, as well as external opportunities and threats.  It is 
crucial to identify potential problems in order to plan interventions to mitigate adverse effects on 
achieving a goal. 
Strengths.  A strength is that this is a small organization, and the staff has a well-
established rapport with their clients.  With a minimal number of staff members, the possibility 
of consistency in the administration of the screening will be increased.  The provider and staff 
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have the willingness to participate in the project and feel it will be beneficial for their patient 
population.  
Weaknesses.  A potential weakness is that the increased patient appointment allotment 
may be perceived as cumbersome to the provider and staff.  Increased appointment allotment 
may cause an increase in wait time for patients in the lobby or may decrease the total amount of 
patients seen per day.  There will be additional charting for both the medical assistant and the 
provider related to screening, diagnosis, and plan of care.  The secretary may perceive an 
increased workload when the patient checks-in with the additional task of asking the patient to 
complete a PHQ-9 screening.  
Opportunities.  A unique quality of this organization was that it is in a rural location, 
which enables the opportunity to screen for depression in an underserved area.  The patient 
population may feel an increase in thoughtfulness and compassion from the clinic by the 
opportunity of being screened for depression.  Providing an environment for mental health 
consideration and support may increase patient willingness to seek help for depression. 
Threats.  However, a potential threat is the lack of local resources for patients needing 
additional psychological counseling.  The closest psychological counseling centers are 
approximately 20 to 30 miles away from the clinic’s area.  Patients may not have the means of 
transportation to attend referral appointments.  Patient’s paying out of pocket may perceive there 
to be an added cost of the screening to be burdensome and request not to take the screening(s). 
Organizational approval process.  During the spring semester, the project leader had a 
geriatric clinical rotation located at a rural clinic as a nurse practitioner student.  A few patients 
were observed to have depression and needed additional treatment, such as pharmacological or 
psychological assistance.  Depression screening was not a standard process in the organization, 
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and the project leader approached the physician about starting a quality improvement project to 
change the current practice.  The provider was interested and willing to serve as a project 
champion for the project.  As the owner of the clinic, the physician provided an organizational 
approval letter to support the implementation of a depression screening project at the site 
(Appendix E).  
Information technology.  The organization uses Amazing Charts, LLC as their 
Electronic Health Record (EHR).  Amazing Charts, LLC is a subsidiary of Pri-Med (Amazing 
Charts, 2019).  Amazing Charts EHR system is designed for small practices in need of an easy 
and affordable electronic health system.  The CMA will chart the score of the PHQ-9 in each 
individual’s electronic chart.  The physician will write a note regarding his interpretation of the 
screening tool(s) and plan of care.  The data collected during the project implementation will be 
entered into an Excel worksheet for data analysis.  Graphs displaying demographic information 
and project progress will be created using an Excel program.   
Cost Analysis of Materials Needed for Project   
For this project, the estimated cost is relatively low.  The PHQ-9 and C-SSRS are free for 
providers to use in their practice.  Printing of the screening tools for patients to complete is 
estimated at approximately $7.50 (one pack of letter-size print paper of 500 sheets).  Educating 
the staff will occur during a weekday morning prior to patients being seen.  This educational plan 
strategy creates cost savings by allowing staff to attend during a regularly scheduled day 
eliminating the need for additional work time for extra training.  Approximately $30 for food 
will be provided during the training session (Appendix F).  
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Plans for Institutional Review Board Approval 
 The project site does not have a formal Institutional Review Board (IRB) process for 
project approval.  Therefore, the University IRB verification process was completed.  The first 
step was completing the IRB Quality Improvement/Program Evaluation Self-Certification Tool.  
After obtaining approval from the Faculty Lead, the tool was submitted on-line.  The project was 
deemed quality improvement, and immediate response was received, stating that no further IRB 
was required (Appendix G). 
Plan for Project Evaluation 
Demographics.  Staff at the primary clinic consist of a physician, secretary, and certified 
medical assistant.  All non-acute patients will be screened for depression by the clinic staff.  
Patient demographic data to be collected will include gender, race, and age.   
Outcome measurement.  The first project outcome is to evaluate staff adherence in 
administering the PHQ-9 depression screening tool for non-acute patient visits, calculate the 
score, and record the score.  A second project outcome is to have the provider administer the C-
SSRS screening tool, based on the total PHQ-9 score or if item nine is greater than zero, and 
record the C-SSRS score.  The third outcome is to have all non-acute patients complete the PHQ-
9 depression screening tool at the primary care clinic. 
Evaluation tool.  The PHQ-9 Daily Depression Screening Data Collection Tool 
(Appendix H) will be jointly completed by the secretary and the certified medical assistant each 
day.  Data elements to be documented include a patient’s gender, race, age, if the patient was 
seen as non-acute or acute, PHQ-9 score for non-acute visits, and C-SSRS score if administered.   
The project leader will utilize the Weekly Staff Compliance Data Tool (Appendix I) to 
compile data from the PHQ-9 Daily Depression Screening Data Collection Tool,  for all patient 
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visits each week.  Weekly data to be collected will include: the number of patients seen, the 
number of non-acute patient visits, the number of PHQ-9 screenings completed, the number of 
screenings not completed, and the reason.  Additional data collected will include the number of 
total PHQ-9 screenings by score intervals and the number of C-SSRS questionnaires 
administered.  
Data analysis.  Data will be evaluated weekly in reviewing percentages and frequencies 
in the number of patients screened for depression.  The data from the daily collection tool 
information will be entered into an excel spreadsheet weekly, analyzed, and displayed in graphs.  
If there is a negative trend or indications of poor adherence in administering the depression 
screening tool, the project leader will adjust using the PDSA review cycle process.  Additionally, 
C-SSRS questionnaire utilization will be tracked and trended every week.  There are no existing 
organization benchmarks; however, the goal is to have 100% administration of the depression 
screening tool to all non-acute patients and administration of the C-SSRS questionnaire when 
indicated.   
Data management.  No personal health information or personal patient identifiers will be 
collected for the project.  The PHQ-9 Daily Depression Screening Data Collection Tool for the 
medical assistant use will be hard copy to provide a smooth daily workflow.  The tool sheets will 
be kept in a locked drawer and completed without patients present.  Each week, the project 
leader will visit the site, collect and review the daily sheets, and clarify any concerns with the 
certified medical assistant.  Once reviewed, the data will be entered into an Excel program for 
data analysis.  Only the clinic staff and the project leader will have access to completed data 
collection tools.  The hard copy and digital data will be retained until the DNP project is 
completed.  Hard copies of the data tools will be kept in a locked drawer in a locked office at the 
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project site.  The Excel document will be stored on a password-protected computer in a locked 
office.  After the project, hard copies of the data tools will be shredded, and electronic data files 
will be deleted.  
Summary 
 The purpose of this project is to implement a standardized depression screening process 
using the PHQ-9 and C-SSRS screening tools in a clinic setting.  Organizational readiness was 
assessed in collaboration with the clinic provider and staff.  A SWOT analysis identified 
strengths, weaknesses, opportunities, and threats, and the project received organizational site 
approval.  A cost analysis revealed minimal cost to the site and outweighed the potential risks 
identified.   
Staff will be asked to complete a data collection tool to track the number of patients 
screened and the results of the screening.  Weekly reviews will be conducted to evaluate the 
project process and outcomes.  
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Chapter Five:  Implementation Process 
         Chapter Five describes the project setting, participants, implementation plan, and any 
variations in the plan.  The implementation plans include discussion on how participants were 
identified and recruited, actual implementation, and concludes with a discussion of how, and to 
what extent, actual implementation varied from planned implementation. 
Setting 
        The project took place in a rural private Internal Medicine practice.  The practice is located 
in a town with a total population of approximately 1,000 residents, situated in a predominantly 
agricultural area.  The clinic’s service area includes patients residing in surrounding small towns 
and rural areas as much as 30 miles away from the clinic.  The clinic’s patient population 
consists of adults ages 18 and older, with the majority of the clients having multiple chronic 
conditions.  Common examples of health conditions treated at the clinic are hypertension, adult-
onset diabetes, chronic obstructive pulmonary disease, thyroid disease, hypercholesterolemia, 
and obesity.  The clinic is funded almost exclusively through insurance reimbursements.  The 
clinic and its staff members are devoted to improving overall care for the residents of this rural 
area. 
Participants 
 Participants in the project included all three staff members at the primary care clinic.  The 
first participant was a physician, the owner of and sole provider in the clinic.  The physician has 
been practicing medicine for 25 years and has been operating the clinic for 16 years.  The second 
participant was a certified medical assistant (CMA).  The CMA checks the vital signs, updates 
the electronic patient chart with data on the purpose of the visit, medication list, and allergies.  
The CMA also performs any procedures that are needed, such as lab draws or urinalysis.  The 
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third participant was the secretary.  The secretary checks the patients in upon their arrival, 
updates sections in the chart regarding insurance and personal contact information, checks the 
patient out upon completion of the visit, calls referrals as ordered, and schedules future 
appointments.  These three individual participants constituted the entire staff of the clinic.  
Consequently, no staff was excluded from participation in the project. 
Recruitment 
 The project leader approached the clinic provider regarding implementing a depression 
screening process.  Discussions between the provider and project leader established a need for 
depression screening, the value of using the PHQ-9 screening tool, and the role of the follow-up 
C-SSRS questionnaire depending on the PHQ-9 results.  Next, the project leader discussed 
implementing a PHQ-9 depression screening process with the CMA.  The secretary was then 
approached and contributed significant information regarding the coding process for insurance 
reimbursement for depression screening.  The secretary was amenable to participating in 
distributing the PHQ-9 screening tool when patients check-in for their non-acute visit. 
 The three participants expressed a commitment to participating in the project.  Potential 
difficulties that may emerge once project implementation begins were increased staff workload 
relative to new paperwork for patients, increased paperwork for the staff, and increased patient 
appointment time allotment.  
Implementation Process 
 Planned implementation began with ordering, duplicating, and having available for staff 
the PHQ-9 screening tool and the C-SSRS questionnaire.  Scripts were constructed to assist the 
secretary and the CMA in explaining the screening process to patients (see Appendix J).  The 
project leader created data collection tools, both digital and a paper copy, to be utilized by both 
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the clinic staff and the project leader as the project unfolded.  Also, the project leader, in 
collaboration with the project champion, established a date for the beginning of patient screening 
and the completion date for data collection by the staff.   
The next step in project implementation was education for the provider, CMA, and 
secretary.  Education for the provider included an overview of the project’s purpose, scoring, and 
interpretation of the PHQ-9 and C-SSRS questionnaires.  The focus of the education included 
preparing staff for the potential of allotting increase patient time for patient education on 
depression and suicide prevention.  The physician was instructed on where to document the 
results and interventions completed in the EHR.  
 The CMA was educated on how to calculate the PHQ-9 score, identify an at-risk score, 
and how to ensure the provider administers the C-SSRS during the patient-provider visit. 
Education included where the CMA will document the screening scores in the EHR.  A script 
was provided to the CMA as guidance for any patient questions or concerns regarding the 
depression screening tool. 
 The secretary was educated to assure that each patient is given a PHQ-9 screening tool 
for all non-acute patient visits.  A script, for guidance, was provided to the secretary for patients 
who were checking in for the non-acute visit.  The secretary was reminded of the responsibility 
of coding for the screening tool in the electronic chart.  The project leader conducted training 
sessions with the secretary and the CMA regarding the data collection tool to evaluate the 
project.   
As the depression screening tool was implemented into practice, the daily data collection 
tool provided raw data for the project leader to enter weekly into a project Excel spreadsheet to 
track and trend the project progress.  This procedure was part of the Plan-Do-Study-Act cycle.  It 
Depression Screening 43 
was designed to identify as early as possible needed corrections in project implementation as 
well as to provide data to evaluate project outcomes.  Weekly follow-up with staff occurred.  As 
an intervention was needed to be changed or added, the project leader communicated with staff 
on the needed changes. 
The success of the project was determined by the extent to which the two project goals 
were met.  The goals were to have 100% administration of the PHQ-9 screening tool to all 
patients undertaking a non-acute visit to the clinic and to have 100% administration of the C-
SSRS questionnaire when indicated by the PHQ-9 screening tool score. 
Plan Variation 
          There were five PDSA worksheets completed throughout the project implementation 
phase, approximately two weeks apart.  At the beginning of the project, staff compliance with 
administering the tool was less than 65% and did not overtly improve as predicted.  During the 
PDSA cycle reviews, barriers to compliance were explored.  The original plan for the depression 
screening process did change due to staff preference.  The secretary voiced concern with having 
to explain and give out the PHQ-9 screening tool during patient check-in because of the multiple 
tasks that needed attention.  A meeting was held with all staff members, it was agreed that if the 
CMA asked the questions, the patients would be more willing to participate.  The staff believed 
most of the patient population would either refuse to take the screen or would be unable to 
complete the screening due to illiteracy.  The new plan consisted of the CMA verbally asking the 
PHQ-9 questions during the visit work-up for the scheduled appointment.  There was an increase 
in staff compliance giving the depression screening tool during non-acute visits after the staff 
changed the process. 
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 Another barrier revealed during project implementation was the CMA’s anxiety in giving 
the PHQ-9 screening tool.  Re-education of the purpose of the screening, using the script 
provided, and providing role-playing for her to practice asking questions increased her 
compliance with giving the screening tool.   
Summary 
        The need for depression screening was identified, and the project champion agreed to 
support the implementation of the PHQ-9 tool during non-acute visits.  In order to obtain support 
from staff and implement the change process, education, a process plan, and script were 
provided.  The implementation process was evaluated approximately every two weeks using the 
PDSA worksheet, and decisions were made to abandon or adopt new process procedures.  Staff 
compliance increased with changes in process based on feedback provided and adapting to meet 
the identified staff needs.  
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Chapter Six:  Evaluation of the Practice Change Initiative 
It is not sufficient to simply report the details of planning the project, implementing the 
change, and gathering outcome data.  This information must also be analyzed in the context of 
project outcomes and goals.  Chapter Six will present the results of the PDSA cycles, areas of 
project successes, and areas where improvement is needed, all in the framework of project 
outcomes and goals.  Information regarding the demographics of the project participants and 
patient population will also be included.  
Participant Demographics 
           All patients who were seen at the clinic during the project period were 18 years of age and 
older.  During the 13-week implementation period, a total of 352 patients were seen for non-
acute reasons.  Of the 352 patients, 87% (312) completed the PHQ-9 depression screening tool.  
Of the 312 patients that completed the screening tool, 143 were females (45.8%) with an average 
age of 61.7 years.  The average age for the 169 males (54.2%) was 60.33 years.  The ethnicity of 
the aforementioned patients was 68% (212) white, 31% (96) African American, and 1% (4) 
other, such as Portuguese and Native American.   
Intended Outcome(s)  
The desired outcome for this project was to introduce a depression screening process into 
this clinic’s standard operating procedure.  The short-term goal was to change the process of 
checking in patients for an appointment and include a standard screening tool for identifying 
patient depression.  The intermediate goals were to give the provider an indication whether or not 
the patient is actively depressed and afford the provider an opportunity to address suspected 
depression during a non-acute appointment.  The long-term goals are to have the provider 
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integrate the PHQ-9 screening tool as a standard diagnostic procedure, treat identified patient 
depression, and assess if treatment is effective.   
Findings  
Of the 312 patients who completed the PHQ-9 screening tool, 96% (299) scored 0-4 on 
the PHQ-9 screening, and 4% (13) received a score between 5-9.  These score ranges are 
significant in that a score of 0-4 indicates minimal depression, and quarterly monitoring is 
suggested.  A score of 5-9 indicates mild depression, in which the use of the provider’s 
judgement in appropriate treatment with quarterly monitoring is recommended.  To further 
delineate the PHQ-9 scores, 46% (144) scored a zero, 18% (57) scored a one, 15% (48) scored a 
two, 9% (29) scored a three, 6% (20) scored a four, 3% (8) scored a five.  Of the patients, three 
scored a six, two scored an eight, and one scored a nine.  The medical assistant calculated the 
PHQ-9 score for each patient, entered the score into the chart, and informed the physician of the 
score.  The physician evaluated the score and adjusted his patient assessments according to the 
score.  There were no patients that met the criteria for the follow-up C-SSRS questionnaire to be 
given.  
 Overall, there was a steady progression towards the ultimate goal of 100% compliance in 
administering the screening tool (Appendix K).  Week 6 revealed a drop in the rate of 
compliance to 83%.  Upon further investigation, during a PSDA cycle, causative obstacles were 
identified.  The secretary was overwhelmed with multiple tasks and did not want to give out the 
screening tool upon patient check-in.  As a corrective measure, the medical assistant agreed to 
start giving the screening tool during her workup for the patient visit.  After that change was 
implemented, improvement resumed but still did not achieve 100% as expected.  During another 
PDSA cycle, it was determined that the medical assistant felt the patients did not read the 
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questionnaire, either by choice or due to illiteracy.  As a corrective measure, the medical 
assistant started reading the questions to the patients and clarifying the responses as needed.  
Based on that change, 100% compliance was achieved during weeks 10 and 12.  The provider 
was able to address depression issues with all patients whose PHQ-9 screening tool scores 
indicated potential depression symptoms. 
Summary 
The depression screening procedure was introduced and implemented as part of patient 
check-in procedures at the clinic.  Biweekly PDSA cycles were conducted to assess the progress 
of the project implementation.  Based on data and feedback derived from the PDSA cycles, 
procedural changes were implemented, and outcomes improved.  The project’s goal of reaching 
100% weekly compliance in administering the PHQ-9 depression survey was achieved twice 
during the later weeks of the 13-week project implementation process.  The majority of the 
patients scored a zero on the PHQ-9 questionnaire.  The physician was provided an opportunity 
to further assess potential depression with each patient whose PHQ-9 questionnaire score was 
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Chapter Seven: Implications for Nursing Practice 
 The American Association of Colleges of Nursing (AACN) describes the Doctor of 
Nursing Practice (DNP) as a practice-focused terminal degree (2006).  DNP graduates are 
innovative clinicians who lead by applying evidence-based practice to improve patient health 
outcomes (Edwards, Coddington, Erler, & Kirkpatrick, 2018).  Eight core DNP essentials create 
the foundational competencies to be mastered by all graduates to prepare them for their advanced 
nursing practice roles (AACN, 2006).  These eight essentials have guided this quality 
improvement (QI) project, the goal of which has been to implement a depression screening 
process in a primary care clinic.  Chapter Seven will define each of these eight essentials and 
explain how it applies to this QI project.   
             Essential I: Scientific underpinnings for practice.  The first essential describes the 
scientific foundations, or the knowledge base, for advanced nursing practice.  Advance nurse 
practitioners need to be able to confront current and future issues that affect healthcare.  This 
requires a firm scientific foundation (AACN, 2006).  Scientific underpinning includes integrating 
nursing science with knowledge from both natural and social sciences, including biology, 
physiology, psychology, and ethics (AACN, 2006).  Theories and development of mid-range 
theories to guide and enhance health care delivery are also scientific underpinnings for advance 
nursing practice (Chism, 2013).    
Scientific underpinnings of this QI project include an extensive literature review and 
additional research on depression screening in the primary care setting.  The Change Theory, by 
Kurt Lewin, guided the structure of this QI project.  This theory states that in order for change to 
be successfully implemented, people involved need to be prepared and educated on the 
importance of the change desired.  The research supported the development of the project by 
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showing depression to be a public health issue that is often under-diagnosed and under-treated in 
the primary care setting.  Research provided evidence that screening tools are sensitive and cost-
effective methods of evaluating depression in the primary care population.   
Based on the literature review and findings from this QI project, one future area of study 
that would be beneficial is a project including not only the identification of but also the treatment 
plan for patients that meet criteria for a diagnosis of depression.  Collaboration between multiple 
interdisciplinary team members engaged in both diagnosis and treatment of depression could 
bolster the patient’s overall health and mental health. 
             Essential II: Organization and systems leadership for quality improvement and 
systems thinking.  DNP graduates must be skilled in assessing an organization’s issues, 
evaluating the cost-effectiveness of change, and executing the implementation of an 
organization-wide change to improve patient care delivery based on scientific findings (AACN, 
2006).  This QI project was developed based on the need to implement a depression screening at 
a primary care clinic.  Practical strategies were developed for the health care clinic, finances 
were considered, and using the Plan-Do-Study-Act model allowed for an accurate evaluation of 
the project’s implementation.  Patient safety initiatives were implemented to protect 
confidentiality and provide additional screening for suicide if warranted.  
             Essential III: Clinical scholarship and analytical methods for EBP.  The third 
essential explains that the DNP graduate should intently apply evidence-based research in 
practice (AACN, 2006).  This project leader applied the third essential throughout this QI 
project.  First by researching and critically analyzing existing literature to identify the best 
screening tool for depression.  The levels of evidence were considered when finding research to 
support the validity of the PHQ-9 and C-SSRS screening tools.  Secondly, by designing a 
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process to implement and evaluate if there was an increase in patients identified with depression.  
Lastly, the third essential was used by disseminating the findings and providing information for 
the practice to improve healthcare outcomes of their patient population.  
             Essential IV: Information systems/technology and patient care technology for the 
improvement and transformation of healthcare.  The AACN (2016) defines this essential as 
using information technology in ways to improve clinical decision-making and ultimately 
improve patient outcomes.  Essential IV was used throughout this QI project, as well.  Data 
mining was used for researching depression and screening.  Technology was used to identify the 
tools for screening depression and staff compliance for administering the tool.  Excel was used 
for data collection and organization, as well as making graphs to display findings.  Also, 
communication between the project leader and staff was done via technology as needed, such as 
utilizing email, texts, or phone calls.  
             Essential V: Healthcare policy for advocacy in healthcare.  The AACN describes the 
importance of DNP graduates being able to analyze healthcare policies and then carefully 
implement those policies (2006).  Advocating for effective health care policy is necessary for the 
DNP graduate to ensure social justice and equity in health care (AACN, 2006).  The Healthy 
People 2020 objectives for mental health and mental health disorders were reviewed for this QI 
project.  The policy goals included increasing depression screening in primary care settings.  
Identifying depression with a valid screening tool, such as the PHQ-9, allowed the clinic to 
achieve the goals set by the Office of Disease Prevention and Health Promotion by increasing 
their population’s access to adequate treatment, assessment of the quality of treatment, and 
increase their quality of life.  The DNP graduates are prepared to advocate for the changes in 
healthcare policies and ensure social equity in health care. 
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             Essential VI: Interprofessional collaboration for improving patient and population 
health outcomes.  Essential VI prepares the DNP graduate for being able to communicate with 
multiple interdisciplinary professionals in an efficient, effective, and patient-centered manner 
(AACN, 2006).  Advanced nurse practitioners will need to frequently collaborate among 
professionals from other professions (Chism, 2013).  This essential is the core of this QI project.  
Communicating with a team to create, implement, and evaluate the intervention has been the 
catalyst for making the project come to life.  Examples of the different professionals involved in 
this project are professors, research collaborators, librarians, the site champion, and staff of the 
clinic.  During the implementation of the depression screening tool, this project leader 
encouraged participants, participated as a team member, and acted as a consultant during the 
time of change.   
             Essential VII: Clinical prevention and population health for improving the nation’s 
health.  This DNP essential prepares the advanced nurse practitioner to “analyze 
epidemiological, biostatistical, occupational, and environmental data in the development, 
implementation, and evaluation of clinical prevention and population health” (AACN, 2006, 
p.15).  Healthy People 2020 supports the promotion of mental health in the population of 18 
years and older.  This project leader assumed the role of promoter of early detection of 
depression screening in a primary care clinic, thus reducing the risk of decreased quality of life 
for the clinic’s population.  
             Essential VIII: Advanced nursing practice.  The final DNP essential explains the 
foundational practice requirements necessary for all graduates.  Per AACN,  the DNP 
professional should be competent in performing a systematic assessment and incorporate 
culturally sensitive strategies to complex situations (2006).  DNP graduates should be able to 
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start and maintain professional relationships with patients and other healthcare affiliates to 
provide the best patient-centered care.  Evaluating evidence-based research and use clinical 
judgment when delivering care is essential for the DNP graduate to educate, guide, and mentor 
patients and other nurses through complex health problems (AACN, 2006).  The DNP program 
prepares the nurse specialist to design, implement, and evaluate interventions completed using 
evidence-based science.  Ultimately, the advanced nurse practitioner is the leader to initiate 
change for patient-centered and organizational-improvement goals. 
Summary  
        Over the past forty years, nursing education at the doctoral level has evolved, and more 
nursing related doctoral degrees have developed (Chism, 2013).  The DNP program prepares a 
nurse at the highest level of advanced practice to improve patient health outcomes (Chism, 
2013).  In today’s complex healthcare system, DNP programs must produce advanced nurse 
specialists committed to a practice career and leadership across diverse practice settings.  The 
AACN developed these eight Essentials of Doctoral Education for Advanced Nursing Practice to 
provide a foundation of competencies that all graduates must achieve.  DNP graduates are 
responsible for being knowledge navigators, practice experts, and caring holistically for patients 
via continuous interactions and evaluations of outcomes. 
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Chapter Eight: Final Conclusions 
Depression is a common disorder that is underdiagnosed and undertreated.  Agencies 
worldwide and nationally have recognized this inadequacy in healthcare and have set goals of 
improving depression recognition and treatment.  Active screening for depression allows primary 
care providers to detect depression and begin to treat this condition at their care visits.  This 
chapter draws upon all that has been planned, organized, implemented, analyzed, and discovered 
through the life of this DNP project.  Chapter Eight will present the project’s significant findings, 
strengths, weaknesses, limitations and benefits, and recommendations for practice. 
Significance of Findings  
           Screenings for depression are as vital as screening for other physical diseases, such as 
high cholesterol and diabetes.  Often the first indication a patient needs mental health help is 
identified through screenings (Genesight, 2019).  As described in Chapter Six, 312 patients 
completed the PHQ-9 screening during the 13-week project implementation period.  All of the 
patients were provided an opportunity to assess their symptoms as related to depression.  During 
the project, only 13 patients scored 5-9 on the PHQ-9, which was associated with mild 
depression.  The patient’s self-reporting of symptoms associated with depression allowed the 
provider to further evaluate for signs of depression, offer assistance in providing referral 
information, and initiating treatment plans as needed.  
 A significant finding was that, fortunately, none of the patients met the criteria to take the 
Columbia-Suicide Severity Rating Scale (C-SSRS).  Nonetheless, screening for suicidal thoughts 
in primary care puts providers at unique positions to make a difference in someone’s life.  The 
questionnaire takes a few minutes to complete and it helps the provider accurately identify the 
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level of support the patient requires.  Both the PHQ-9 and C-SSRS screenings open the door to 
earlier diagnosis and treatment (Genesight, 2019).  
Project Strengths and Weaknesses 
          The project strengths included:  (1) positive staff support in implementing the depression 
screening, (2) low cost, and (3) an easy-to-interpret screening tool.  Support and collaboration 
from the project champion and office staff allowed the project idea to come to fruition.  
Throughout the project, during the PDSA cycles, staff were receptive to discussing how changes 
could improve compliance with the protocols for the administration of the PHQ-9 screening tool.  
Overall, the screening process proved cost-effective because Pfizer Inc. (2017) grants permission 
to use the PHQ-9 questionnaire for free.  The tool makes it easy to calculate the score and to 
interpret the depression severity based on the score that would guide further evaluation.  
Recommendations for treatment of each severity of depression are provided and clinical 
judgment of the course of treatment is encouraged.  
A weakness identified was that many of the patients were not willing to or unable to read 
and understand the nine-item questionnaire.  This led to an increased workload for the secretary, 
and she was unable to ensure everyone completed the questionnaire upon check-in to the clinic.  
Ultimately the certified medical assistant (CMA) began asking the questions during her check-in 
process to ensure completion of the questionnaire.  Initially, the CMA experienced a learning 
curve in adjusting to and feeling comfortable with asking the questions of the patients.  After 
discussing these adjustments during a PDSA cycle, the CMA was able to overcome feeling of 
being uncomfortable and assist the patients in responding to the questionnaire accurately.  This 
process added to the CMA’s overall workload as she was spending more time administering the 
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questionnaire, calculating the score to inform the provider, and entering the PHQ-9 score into the 
EHR.  
Project Limitations 
          Limitations of the project were identified to mainly revolve around time restraints.  One 
limitation was based on the time constraints of the project’s 13-week implementation period.  
There were steady improvements during the implementation with project tweaking based on the 
PDSA cycle reviews.  Compliance improved toward the end of the 13-weeks and may have 
continued to stay at the goal of 100% if the project was conducted over a longer period.   
The second time constraint was the staff adjusting to a new initiative incorporated into 
their usual daily routine.  The secretary’s role was to give the PHQ-9 during check-in, but she 
became overwhelmed with multiple tasks and requested not to do it.  The CMA assumed 
responsibility for the screening and, in doing so, had to extend her patient check-in process.  
Once she was more familiar with the questionnaire administration, her check-in process became 
quicker.  The CMA was also responsible for completing the PHQ-9 Daily Depression Screening 
Data Collection Tool daily.  This was done by writing out the information needed for data 
collection on paper format.  This task did, indeed, add time and responsibilities to the CMA’s 
daily routine. 
A third time constraint or limitation was the length of the screening tool.  Through a 
PDSA cycle, the staff decided the CMA asking the patients the PHQ-9 questions would ensure 
better compliance of depression screening.  Assisting the patients to fill out the questionnaire 
was time-consuming for the CMA and extended her check-in time, impacting patient throughput.  
Some primary care practices screen with the PHQ-2 questionnaire, which consists of just two 
questions and, depending on those results, possible follow-up administration of the PHQ-9.  
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Patients may be more receptive to a quicker, less intimidating questionnaire, and this would be 
less time consuming for the CMA’s check-in process. 
Project Benefits 
          Early interventions can improve lives and may save a patient from harming themselves.  
This project impacted the community by providing a standardized approach in screening for a 
potentially debilitating mental health illness and triggered a conversation between patient and 
provider, often leading to effective treatment plans.  With effective treatment plans, depression 
can decrease, which will increase the patient’s self-efficacy to adhere to their medical treatment 
(Adam & Folds, 2014).   
Implementing the PHQ-9 depression screening allows the clinic to meet goals associated 
with the Healthy People 2020 objectives for mental health by increasing the frequency of 
depression screening in the primary care setting, which may increase the number of adults that 
receive treatment.  The PHQ-9 depression screening also meets the IHI’s Triple Aim goals by 
providing exceptional quality of care at an efficient cost, while improving the health of the 
population.  Depression creates a more considerable economic strain by increasing healthcare 
resources and decreasing work productivity (Chow et al., 2019).  Chow et al. (2019) performed a 
retrospective analysis to determine if this economic strain differed among the severities of 
depression, as defined by the PHQ-9 questionnaire.  In this analysis, the PHQ-9 scores were 
categorized as 0-4 (no to minimal depression), 5-14 (mild to moderate), and 15-27 (moderately 
severe to severe).  Overall, the authors found that the more severe the depression correlated with 
higher work productivity impairment, increased direct cost (increased ED visits and 
hospitalizations) and increased indirect cost (absenteeism-related cost).  By early screening for 
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depression and starting treatment sooner, the total cost and functional impairment can be reduced 
for each patient, and thus the population. 
 The Suicide Prevention Resource Center (2020) explains that every $1.00 spent on 
interventions to improve interprofessional collaboration between clinicians to provide 
psychotherapeutic interventions would save $2.50 in the cost of suicides.  The cost savings that 
can result from screening for suicidal ideations will save US dollars as well as save lives. 
Practice Recommendations 
          Based on the findings, strengths, weaknesses, limitations, and benefits of the project, 
continuing depression screening in this community-based practice is essential to improving the 
care provided at this clinic.  This project’s focus was on implementing a process to screen for 
depression.  It would be beneficial to have an alert system in the EHR at the clinic to ensure that 
PHQ-9 screenings are done yearly, and if there were changes in a patient’s depression treatment 
plan, alert the provider to screen at the follow-up visits to assess for effectiveness.   
However, recognizing and diagnosing depression is just the first step in treating mental 
illness.  One recommendation is to develop an inter-professional network with other specialties 
to meet the patient needs holistically.  For example, a team or coordinator who can connect 
patients to social workers, psychiatrists, physical therapy, occupational therapy, or community 
centers, is needed for the extended care of the patient.  Collaborative care has been shown to 
significantly improve patient outcomes and enrich patient’s overall well-being (Smithson & 
Pignone, 2017; Jiao et al., 2017; Kwan et al., 2017; Zivin & Katon, 2015).   
Another recommendation is to continue to use the PDSA cycle to implement change in 
this clinic.  The staff has proven to be receptive to new ideas that benefit their patient population.  
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If more changes are desired, the PDSA cycle was proven to be a useful tool in tracking the 
clinic’s progress in implementing an intervention to improve patient outcomes.   
Final Summary 
          Depression is a mental illness that affects one’s thoughts, feelings, and actions.  It does not 
discriminate against age, race, ethnicity, and gender.  Having depression does increase the risk of 
suicidal ideation.  Depression expands beyond the patient and can have adverse effects on others, 
such as family members and employers.  Screening for depression has been proven to be 
effective in early recognition and diagnosis.  Integrating depression into routine primary care 
screening will benefit the patient population in this rural clinic by initiating conversations of 
depression, early identification, treatment plans, and referrals.   
 Physical and mental health are intertwined.  Unmanaged depression can worsen a 
patient’s chronic physical health problems.  Early identification and treatment of depression may 
reduce personal financial medical costs, increase the self-efficacy of one’s health plan, and 
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Appendix A 
Literature Search Strategy 
 
  SEARCH STRATEGY 
 
 
-depression OR major depressive disorder AND patient health 
questionnaire AND primary care setting AND within five years 





-adults and older adults with depression AND peer-reviewed AND 
last five years AND english language AND depression screening 
AND implementing depression screening AND process measures 
AND depression screening instruments AND PHQ-9 AND primary 
care AND improvement in depression screening = 83 articles 
 
 One-Search Database 
After combining the two searches, removing duplicate articles, and 
reviewing abstracts = 32 articles included 
+ 
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Appendix D 
Columbia-Suicide Severity Rating Scale 
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Appendix E 
Community Letter of Support 
 










Materials   
Pack of letter 
size print 
paper  1  $      7.50   $      7.50      
Materials 
Reproduction   Sheets 500  $      0.10   $    50.00      
Food   
Refreshments 
for education 
session 1  $    30.00   $    30.00      
               
TOTAL          $    87.50      
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Appendix G 
Quality/Program Evaluation Worksheet 
Quality Improvement/Program Evaluation Self-Certification Tool 
Purpose: 
Projects that do not meet the federal definition of human research pursuant to 45 CFR 46 do not 
require IRB review. This tool was developed to assist in the determination of when a project falls 
outside of the IRB’s purview. 
 
Instructions: 
Please complete the requested project information, as this document may be used for 
documentation that IRB review is not required. Select the appropriate answers to each question 
in the order they appear below. Additional questions may appear based on your answers. If you 
do not receive a STOP HERE message, the form may be printed as certification that the project 
is “not research”, and does not require IRB review. The IRB will not review your responses as 
part of the self-certification process. 
 




Depression Screening Implementation in a Primary Care Clinic 
 
Brief description of Project/Goals: 
  
Depression is a common disorder that severely impacts one’s quality of life. It can cause 
significant medical, social, and financial ramifications to an individual and affect others close to 
the person suffering from depression. Depression is often underdiagnosed in the primary care 
setting, which can lead to inadequate treatment. Depression screening has been proven to be 
effective in detecting symptoms during an office visit. The intent of this quality improvement 
project is to implement a Patient Health Questionnaire (PHQ-9) depression screening process at 
Vanceboro Internal Medicine. Based on the total score of the PHQ-9 screening test or if question 
number 9 is one or greater, the provider will also administer the Columbia-Suicide Severity 
Rating Scale (C-SSRS) questionnaire to further evaluate suicidal risk. The provider will be 
educated on the purpose and process of implementing the screening tools. Additional staff will 
be educated on the purpose, administration, and billing of the screening tool. The goal is to have 
100% administration of the PHQ-9 screening tool to all non-acute patient visits. Once the project 
has been started, weekly reviews will be conducted, over a 12-week period, to evaluate the 
clinic’s progress and if modifications are needed as the project unfolds. Implementing the project 
in a step-wise fashion will be important to assist the clinic in having a successful integration of a 
depression screening process as a standard of practice. 
 
  Will the project involve testing an experimental drug, device (including medical software or 
assays), or biologic? 
No 
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Has the project received funding (e.g. federal, industry) to be conducted as a human subject 
research study? 
No 
Is this a multi-site project (e.g. there is a coordinating or lead center, more than one site 
participating, and/or a study-wide protocol)? 
No 
Is this a systematic investigation designed with the intent to contribute to generalizable 
knowledge (e.g. testing a hypothesis; randomization of subjects; comparison of case vs. control; 
observational research; comparative effectiveness research; or comparable criteria in alternative 
research paradigms)? 
No 
Will the results of the project be published, presented or disseminated outside of the institution or 
program conducting it? 
Yes 
   Would the project occur regardless of whether individuals conducting it may benefit 
professionally from it? 
Yes 
Does the project involve “no more than minimal risk” procedures (meaning the probability and 
magnitude of harm or discomfort anticipated are not greater in and of themselves than those 
ordinarily encountered in daily life or during the performance of routine physical or 
psychological examinations or tests)? 
Yes 
Is the project intended to improve or evaluate the practice or process within a particular 
institution or a specific program, and falls under well-accepted care practices/guidelines? 
Yes 
 
Based on your responses, the project appears to constitute QI and/or Program Evaluation and 
IRB review is not required because, in accordance with federal regulations, your project does not 
constitute research as defined under 45 CFR 46.102(d). If the project results are disseminated, 
they should be characterized as QI and/or Program Evaluation findings. Finally, if the project 
changes in any way that might affect the intent or design, please complete this self-certification 
again to ensure that IRB review is still not required. Click the button below to view a printable 
version of this form to save with your files, as it serves as documentation that IRB review is not 
required for this project. 6/20/2019 
Powered by Qualtrics 
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Appendix H 
PHQ-9 Daily Depression Screening Data Collection Tool 










1.       
2.       
3.       
4.       
5.       
6.       
7.       
8.       
9.       
10.       
11.       
12.       
13.       
14.       
15.       
 
 
If a patient presented for a non-acute visit and did not complete a PHQ-9 screening 
tool, indicate below the patient number (from above) and the reason why the tool 
was not completed. 
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Appendix I 
Weekly Staff Compliance Data Tool 
 
 Project Week _________          Dates ________________________ 
 
• Total number of patients seen this week _________ 
• Total number of non-acute visits this week _______ 
• Number of PHQ-9 screenings done this week ____________ 
• Number of screenings not completed during non-acute visit ______ 
• Of the PHQ-9 screenings completed, what were the number of cut-off 
scores? 
o 1-4 _______ 
o 5-9 _______ 
o 10-14 _____ 
o 15-19 _____ 
o 20-27 _____ 




• Number of C-SSRS questionnaires administered  __________ 
  





Please fill this form out while you wait to be check-in with the Certified Medical Assistant.  This 
form will allow your doctor to see if you have any symptoms of depression and, if you do, how 
he can help you manage your symptoms to help you feel better.  If you are unable to complete 










Thank you for filling out this form.  I will notify the doctor of your score, and he will discuss the 
results of this form with you during your visit.   
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Appendix K 















1 2 3 4 5 6 7 8 9 10 11 12 13
Weekly Staff Compliance of PHQ-9 Screening 
for Non-Acute Visits 
